Worldwide Lab Automation for In-Vitro Diagnostics Industry to 2027 - Drivers, Restraints, Opportunities and Threats -

DUBLIN--()--The "Lab Automation For In-Vitro Diagnostic - Global Market Outlook (2019-2027)" report has been added to's offering.

The Global Lab Automation for In-Vitro Diagnostics market accounted for $4,315.48 million in 2019 and is expected to reach $8,288.33 million by 2027 growing at a CAGR of 8.5% during the forecast period.

Some of the key factors propelling market growth include flexibility and adaptability of lab automation systems, digital transformation for laboratories with IoT, innovative development in the IVD field, and increasing the demand for early remedies and diagnosis. However, lack of skilled laboratory professionals is likely to hamper the market.

In-vitro diagnostics (IVD) tests are basically medical devices that could be in the form of reagents, techniques, instruments, or a combination of these used in vitro for the examination of specimens, such as blood, urine, or tissue, with the goal of obtaining a diagnosis from assays in a controlled environment. Diagnostic tests are usually conducted in laboratories, private or public, equipped with appropriate and sometimes expensive instrumentation and staffed with trained and qualified personnel to perform the tests. Some IVDs can extend beyond the laboratory, hospital, or doctor's office, thereby empowering patients with chronic diseases to self-monitor and manage their own conditions.

By end user, laboratories are one of the prime recipients of lab automation for In-Vitro diagnostics. Hospitals and private labs are considered as laboratories. Technological innovations have improved the productivity of clinical labs. Owing to the ongoing advances in connected technologies and cloud-based laboratory information management systems (LIMS) platforms, these tools are helping businesses to access the benefits of the digital transformation and provide laboratories a secure way to organize data, making accessing insights quick and easy, while allowing businesses to control which data is sent to third-party instrument vendors.

On the basis of geography, North America region is expected to have considerable market growth during the forecast period, owing to the availability of government funds, stringent FDA regulations, growing use of molecular diagnostics in genetic disorders and cancer screening, and the presence of most of the major players in this region. North America has been a pioneer in clinical research for years. The region also has the highest concentration of contract research organizations (CRO's). Some of the sisgnificant CROs are Laboratory Corp. of America Holdings, IQVIA, Syneos Health, and Parexel International Corp.

Companies Mentioned

  • Siemens Healthineers AG
  • Cognex Corporation
  • Tecan Group Ltd
  • Roche Holding AG
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • F. Hoffmann-La Roche Ltd
  • Bee Robotics Ltd.

What the report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company Profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 End User Analysis

3.7 Emerging Markets

3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Lab Automation for In-Vitro Diagnostics Market, By Equipment

5.1 Introduction

5.2 Automated Storage and Retrieval System

5.3 Analyzer

5.4 Automated Plate Handler

5.5 Robotic Arm

5.6 Automated Liquid Handler

6 Global Lab Automation for In-Vitro Diagnostics Market, By End User

6.1 Introduction

6.2 Laboratory

6.3 Academic

7 Global Lab Automation for In-Vitro Diagnostics Market, By Geography

7.1 Introduction

7.2 North America

7.3 Europe

7.4 Asia Pacific

7.5 South America

7.6 Middle East & Africa

8 Key Developments

8.1 Agreements, Partnerships, Collaborations and Joint Ventures

8.2 Acquisitions & Mergers

8.3 New Product Launch

8.4 Expansions

8.5 Other Key Strategies

9 Company Profiling

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900